People paralyzed by cervical spinal cord injury or amyotrophic lateral sclerosis may be eligible for the study, but Neuralink did not disclose how many people would participate in the trial, which will take about six years to complete.
Neuralink logo and photo of Elon Musk. Photo: REUTERS
The research will use robots to surgically place the chip into the area of the brain that controls the intention to move, Neuralink said, adding that its initial goal is to allow people to control a cursor or computer keyboard using only their thoughts.
Musk has big ambitions for Neuralink, saying it will facilitate the rapid introduction of his chip devices into surgery to treat conditions like obesity, autism, depression and schizophrenia.
In May, the company said it received FDA approval for its first human clinical trial, as the company faces federal scrutiny over its handling of animal testing.
Even if the company's chip device is proven safe for human use, it could still take Neuralink more than a decade to secure approval for commercial use, experts say.
Mai Van (according to Reuters)
Source
![[Maritime News] Container shipping faces overcapacity that will last until 2028](https://vphoto.vietnam.vn/thumb/402x226/vietnam/resource/IMAGE/2025/7/30/6d35cbc6b0f643fd97f8aa2e9bc87aea)
Comment (0)